These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 39287110)

  • 1. Progestogen hypersensitivity: successful use of progesterone desensitisation and omalizumab to facilitate in vitro fertilisation.
    Xu G; Yuson R; Rafferty M; Thai TL; Limaye S
    Intern Med J; 2024 Oct; 54(10):1749-1752. PubMed ID: 39287110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progestogen Sensitization: a Unique Female Presentation of Anaphylaxis.
    Bernstein JA
    Curr Allergy Asthma Rep; 2020 Jan; 20(1):4. PubMed ID: 31993777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progestogen Hypersensitivity.
    Li RC; Buchheit KM; Bernstein JA
    Curr Allergy Asthma Rep; 2018 Jan; 18(1):1. PubMed ID: 29349660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful desensitisation to paclitaxel with omalizumab.
    Barreras N; Gómez-López A; Valverde M; Arranz JL; Castillo E; Hernandez M
    Eur J Hosp Pharm; 2024 Oct; 31(6):592-594. PubMed ID: 37798087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progestogen Hypersensitivity: An Evidence-Based Approach to Diagnosis and Management in Clinical Practice.
    Foer D; Buchheit KM
    Immunol Allergy Clin North Am; 2017 Nov; 37(4):773-784. PubMed ID: 28965640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progestogen Hypersensitivity in 24 Cases: Diagnosis, Management, and Proposed Renaming and Classification.
    Foer D; Buchheit KM; Gargiulo AR; Lynch DM; Castells M; Wickner PG
    J Allergy Clin Immunol Pract; 2016; 4(4):723-9. PubMed ID: 27090357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Omalizumab may facilitate drug desensitization in patients failing standard protocols.
    Gemici Karaaslan HB; Karabag Yilmaz E; Gulmez R; Canpolat N; Kiykim A; Cokugras HC
    Pediatr Allergy Immunol; 2022 May; 33(5):e13783. PubMed ID: 35616895
    [No Abstract]   [Full Text] [Related]  

  • 8. Omalizumab for management of hypersensitivity reactions to anticancer drugs.
    Grover P; Krummenacher M; Loy T; Nowak AK; Lucas M
    Intern Med J; 2024 Aug; 54(8):1396-1400. PubMed ID: 39031469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progestogen Hypersensitivity.
    Chiarella SE; Buchheit KM; Foer D
    J Allergy Clin Immunol Pract; 2023 Dec; 11(12):3606-3613.e2. PubMed ID: 37579875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progestogen Hypersensitivity: Heterogeneous Manifestations with a Common Trigger.
    Buchheit KM; Bernstein JA
    J Allergy Clin Immunol Pract; 2017; 5(3):566-574. PubMed ID: 28483311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anaphylaxis due to progesterone hypersensitivity successfully treated with omalizumab.
    Heffler E; Fichera S; Nicolosi G; Crimi N
    J Allergy Clin Immunol Pract; 2017; 5(3):852-854. PubMed ID: 28258855
    [No Abstract]   [Full Text] [Related]  

  • 12. The place of Omalizumab in the treatment of Carboplatin hypersensitivity.
    Benderli Cihan Y
    J BUON; 2021; 26(5):2205. PubMed ID: 34761641
    [No Abstract]   [Full Text] [Related]  

  • 13. Delayed hypersensitivity reactions to multiple aromatase inhibitors followed by successful desensitization to letrozole.
    Lee EY; Freedman O; Castells M; Vadas P
    Ann Allergy Asthma Immunol; 2021 Sep; 127(3):378-379. PubMed ID: 34004279
    [No Abstract]   [Full Text] [Related]  

  • 14. Documented exogenous progesterone hypersensitivity related to the use of combined oral contraceptive.
    Chamorro-Pareja N; Carrillo-Martin I; Haehn DA; Gonzalez-Estrada A
    BMJ Case Rep; 2019 Sep; 12(9):. PubMed ID: 31501174
    [No Abstract]   [Full Text] [Related]  

  • 15. Role of omalizumab in insulin hypersensitivity: a case report and review of the literature.
    Mishra S; Connors L; Tugwell B
    Diabet Med; 2018 May; 35(5):663-666. PubMed ID: 29381818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin B12 allergy and successful desensitisation with cyanocobalamin: a case report.
    Kartal O; Gulec M; Demirel F; Yesillik S; Caliskaner Z; Sener O
    Allergol Immunopathol (Madr); 2012; 40(5):324-5. PubMed ID: 22266142
    [No Abstract]   [Full Text] [Related]  

  • 17. The use of omalizumab in allergen immunotherapy.
    Dantzer JA; Wood RA
    Clin Exp Allergy; 2018 Mar; 48(3):232-240. PubMed ID: 29315922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid subcutaneous desensitization for the management of delayed hypersensitivity reactions to omalizumab：A case report.
    Gan H; Wang L; Fu W; Zhang J; Yu M; Liu G
    J Clin Pharm Ther; 2019 Jun; 44(3):486-488. PubMed ID: 30859588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case of cow's milk allergy treated with rush oral immunotherapy with omalizumab.
    Iwasaki Y; Okada Y; Imai T
    Pediatr Int; 2024; 66(1):e15802. PubMed ID: 39076029
    [No Abstract]   [Full Text] [Related]  

  • 20. Oral Immunotherapy for Food Allergy.
    Wood RA
    J Investig Allergol Clin Immunol; 2017; 27(3):151-159. PubMed ID: 28102823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.